Trial Profile
A post-marketing study of patiromer in paediatric patients
Status:
Planning
Phase of Trial:
Phase IV
Latest Information Update: 01 Mar 2016
Price :
$35
*
At a glance
- Drugs Patiromer (Primary)
- Indications Hyperkalaemia
- Focus Adverse reactions
- 01 Mar 2016 New trial record
- 24 Feb 2016 This trial is expected to begin in late 2016, according to a Relypsa media release.